Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardent Health (ARDT) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $141.2 million.

  • Ardent Health's Shares Outstanding (Weighted Average) rose 300.44% to $141.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.2 million, marking a year-over-year increase of 300.44%. This contributed to the annual value of $132.4 million for FY2024, which is 501.48% up from last year.
  • Latest data reveals that Ardent Health reported Shares Outstanding (Weighted Average) of $141.2 million as of Q3 2025, which was up 300.44% from $140.4 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's Shares Outstanding (Weighted Average) ranged from a high of $141.2 million in Q3 2025 and a low of $126.1 million during Q2 2023
  • Its 3-year average for Shares Outstanding (Weighted Average) is $132.2 million, with a median of $129.3 million in 2023.
  • As far as peak fluctuations go, Ardent Health's Shares Outstanding (Weighted Average) changed by 0.0% in 2024, and later soared by 1130.68% in 2025.
  • Quarter analysis of 3 years shows Ardent Health's Shares Outstanding (Weighted Average) stood at $126.1 million in 2023, then increased by 5.01% to $132.4 million in 2024, then rose by 6.63% to $141.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $141.2 million for Q3 2025, versus $140.4 million for Q2 2025 and $140.1 million for Q1 2025.